| Item Type | Name |
|
Academic Article
|
Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
|
|
Academic Article
|
Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.
|
|
Academic Article
|
Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.
|
|
Academic Article
|
Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.
|
|
Academic Article
|
Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
|
|
Academic Article
|
Cutaneous model of invasive aspergillosis.
|
|
Academic Article
|
Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.
|
|
Academic Article
|
Activity of deferasirox in Mucorales: influences of species and exogenous iron.
|
|
Academic Article
|
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
|
|
Academic Article
|
Posaconazole: a broad-spectrum triazole antifungal.
|
|
Academic Article
|
Sinus zygomycosis in a patient receiving voriconazole prophylaxis.
|
|
Academic Article
|
Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
|
|
Academic Article
|
Risk factors for mortality in patients with mucormycosis.
|
|
Academic Article
|
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
|
|
Academic Article
|
Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis.
|
|
Academic Article
|
Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.
|
|
Academic Article
|
Mitochondrial respiratory pathways inhibition in Rhizopus oryzae potentiates activity of posaconazole and itraconazole via apoptosis.
|
|
Academic Article
|
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.
|
|
Academic Article
|
Recent advances in the management of mucormycosis: from bench to bedside.
|
|
Academic Article
|
Combination therapy for mucormycosis: why, what, and how?
|
|
Academic Article
|
Deferasirox lacks in vitro activity against Fusarium and Scedosporium species and black molds.
|
|
Academic Article
|
Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-?.
|
|
Academic Article
|
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.
|
|
Academic Article
|
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
|
|
Academic Article
|
Challenges in designing animal studies to detect antagonism of polyene activity.
|
|
Academic Article
|
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
|
|
Academic Article
|
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.
|
|
Academic Article
|
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
|
|
Academic Article
|
Posaconazole prophylaxis in hematologic cancer.
|
|
Academic Article
|
Random plasma concentrations of voriconazole decline over time.
|
|
Academic Article
|
Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection.
|
|
Academic Article
|
Invasive mycoses: strategies for effective management.
|
|
Academic Article
|
Future directions in mucormycosis research.
|
|
Concept
|
Triazoles
|
|
Academic Article
|
Hyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action through apoptosis.
|
|
Academic Article
|
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.
|
|
Academic Article
|
Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia.
|
|
Academic Article
|
Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.
|
|
Academic Article
|
Switching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity.
|
|
Academic Article
|
Complex interaction of deferasirox and Pythium insidiosum: iron-dependent attenuation of growth in vitro and immunotherapy-like enhancement of immune responses in vivo.
|
|
Academic Article
|
Breakthrough zygomycosis and voriconazole.
|
|
Academic Article
|
Isavuconazole: a new extended spectrum triazole for invasive mold diseases.
|
|
Academic Article
|
The 'cephalosporin era' of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections.
|
|
Academic Article
|
Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
|
|
Academic Article
|
Effect of preexposure to triazoles on susceptibility and virulence of Rhizopus oryzae
|
|
Academic Article
|
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
|
|
Academic Article
|
Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents.
|
|
Academic Article
|
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
|
|
Academic Article
|
Heat shock protein 90 and calcineurin pathway inhibitors enhance the efficacy of triazoles against Scedosporium prolificans via induction of apoptosis.
|
|
Academic Article
|
Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses.
|
|
Academic Article
|
Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels.
|
|
Academic Article
|
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
|
|
Academic Article
|
Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions.
|
|
Academic Article
|
Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole.
|
|
Academic Article
|
Tolerability of isavuconazole after posaconazole toxicity in leukaemia patients.
|
|
Academic Article
|
Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.
|
|
Academic Article
|
Serum Levels of Crushed Posaconazole Delayed-Release Tablets.
|
|
Academic Article
|
Lack of Toxicity With Long-term Isavuconazole Use in Patients With Hematologic Malignancy.
|
|
Academic Article
|
Screening the in vitro susceptibility of posaconazole in clinical isolates of Candida spp. and Aspergillus spp. and analyzing the sequence of ERG11 or CYP51A in non-wild-type isolates from China.
|
|
Academic Article
|
A Novel Broad Allele-Specific TaqMan Real-Time PCR Method To Detect Triazole-Resistant Strains of Aspergillus fumigatus, Even with a Very Low Percentage of Triazole-Resistant Cells Mixed with Triazole-Susceptible Cells.
|
|
Academic Article
|
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.
|
|
Academic Article
|
Azole-Associated Pseudohyperaldosteronism: A Class Effect or Azole-Specific?
|
|
Academic Article
|
Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.
|
|
Academic Article
|
Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy.
|
|
Academic Article
|
How different is invasive fusariosis in pediatric patients than in adults? A systematic review.
|
|
Academic Article
|
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study.
|
|
Academic Article
|
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies.
|
|
Academic Article
|
Triazole Priming as an Adaptive Response and Gateway to Resistance in Aspergillus fumigatus.
|
|
Academic Article
|
Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes.
|